Solid Biosciences Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep '25 Sep 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Cash & Equivalents	61.36	80.24	74.02	155.38	119.14	154.74
Short-Term Investments	174.78	68.69	49.63	58.34	88.64	-
Cash & Short-Term Investments	236.14	148.92	123.64	213.72	207.78	154.74
Cash Growth	38.00%	20.45%	-42.15%	2.86%	34.27%	85.27%
Other Receivables	-	-	-	-	0.11	-
Total Trade Receivables	-	-	-	-	0.11	-
Other Current Assets	8.71	8.38	6.09	5.92	14.72	4.16
Total Current Assets	244.85	157.3	129.73	219.64	222.61	158.9
Net Property, Plant & Equipment	26.89	29.04	33.16	38.61	7.6	11.73
Other Long-Term Assets	2.17	2.32	2.04	2.01	2.16	0.54
Total Assets	273.91	188.66	164.94	260.25	232.38	171.17
Accounts Payable	8.43	4.24	2.03	3.24	4.46	3.27
Accrued Expenses	19.05	19.85	10.16	16.69	9.53	8.64
Current Portion of Leases	2.31	3.02	2.32	2.57	1.5	2.21
Unearned Revenue	-	-	-	-	8.08	10.36
Other Current Liabilities	6.55	3.15	-	0.01	0.04	-
Total Current Liabilities	36.34	30.26	14.52	22.51	23.6	24.48
Long-Term Leases	19.62	21.16	23.94	25.98	0.57	2.94
Other Long-Term Liabilities	-	-	-	0.1	-	11.66
Total Long-Term Liabilities	19.62	21.16	23.94	26.08	0.57	14.6
Total Liabilities	55.97	51.42	38.46	48.59	24.17	39.08
Common Stock	0.08	0.04	0.02	0.02	0.01	0.09
Additional Paid-in Capital	1,126	920.61	785.2	774.45	685.01	536.57
Accumulated Other Comprehensive Income	0.05	0.05	0.02	-0.07	-0.05	-
Retained Earnings	-907.99	-783.45	-658.75	-562.74	-476.76	-404.57
Shareholders' Equity	217.95	137.25	126.48	211.67	208.21	132.09
Total Liabilities & Equity	273.91	188.66	164.94	260.25	232.38	171.17
Total Debt	21.94	24.18	26.27	28.55	2.06	5.15
Net Cash (Debt)	214.21	124.74	97.38	185.18	205.72	149.59
Net Cash Growth	71.72%	28.11%	-47.41%	-9.98%	37.52%	95.66%
Net Cash Per Share	2.88	3.06	4.90	21.75	28.90	43.20
Book Value	217.95	137.25	126.48	211.67	208.21	132.09
Book Value Per Share	2.93	3.36	6.36	24.87	29.25	38.15
Tangible Book Value	217.95	137.25	126.48	211.67	208.21	132.09
Tangible Book Value Per Share	2.93	3.36	6.36	24.87	29.25	38.15

Updated Nov 3, 2025. Data Source: Fiscal.ai. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q